Novel monocyte biomarkers of atherogenic conditions

Current Pharmaceutical Design

Volumn 19, Issue 33, 2013, Pages 5859-5864

  Gratchev, Alexei ^a,c   Ovsiy, Ilja ^a   Manousaridis, Ioannis ^a   Riabov, Vladimir ^a   Orekhov, Alexander ^b,d   Kzhyshkowska, Julia ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^d Skolkovo Innovative Centre   (Russian Federation)

Author keywords

Atherogenic conditions; Biomarkers; Monocyte

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17 RECEPTOR B; INTERLEUKIN 4; SCAVENGER RECEPTOR; STABILIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXQ1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; EPITHELIAL MESENCHYMAL TRANSITION; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES, NEURONAL; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MACROPHAGES; MONOCYTES; RECEPTORS, INTERLEUKIN; RECEPTORS, LYMPHOCYTE HOMING;

EID: 84884244853     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319330004     Document Type: Article

References (84)

1. Geissmann F, Gordon S, Hume DA, Mowat AM, Randolph GJ. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 2010; 10(6): 453-60.
2. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32(5): 593-604.
3. Joris I, Zand T, Nunnari JJ, Krolikowski FJ, Majno G. Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am J Pathol 1983; 113(3): 341-58.
4. Alderson LM, Endemann G, Lindsey S, Pronczuk A, Hoover RL, Hayes KC. LDL enhances monocyte adhesion to endothelial cells in vitro. Am J Pathol 1986; 123(2): 334-42.
5. Cybulsky MI, Gimbrone MA, Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251(4995): 788-91.
6. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992; 140(3): 665-73.
7. Sadhu C, Ting HJ, Lipsky B, et al. CD11c/CD18: novel ligands and a role in delayed-type hypersensitivity. J Leukoc Biol 2007; 81(6): 1395-403.
8. van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 1992; 141(6): 1427-33.
9. Wu H, Gower RM, Wang H, et al. Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 2009; 119(20): 2708-17.
10. Bath PM, Gladwin AM, Martin JF. Human monocyte characteristics are altered in hypercholesterolaemia. Atherosclerosis 1991; 90(2-3): 175-81.
11. Han KH, Ryu J, Hong KH, et al. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Circulation 2005; 111(11): 1439-47.
12. Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology 2012; 217(5): 476-82.
13. Grage-Griebenow E, Lorenzen D, Fetting R, Flad HD, Ernst M. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol 1993; 23(12): 3126-35.
14. Ancuta P, Liu KY, Misra V, et al. Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and. BMC Genomics 2009; 10: 403.
15. Weber C, Belge KU, von Hundelshausen P, et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 2000; 67(5): 699-704.
16. Rothe G, Gabriel H, Kovacs E, et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996; 16(12): 1437-47.
17. Draude G, von Hundelshausen P, Frankenberger M, Ziegler-Heitbrock HW, Weber C. Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset. Am J Physiol 1999; 276(4 Pt 2): H1144-H1149.
18. Merino A, Buendia P, Martin-Malo A, Aljama P, Ramirez R, Carracedo J. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J Immunol 2011; 186(3): 1809-15.
19. Kashiwagi M, Imanishi T, Tsujioka H, et al. Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. Atherosclerosis 2010; 212(1): 171-6.
20. Mosig S, Rennert K, Krause S, et al. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL. FASEB J 2009; 23(3): 866-74.
21. Kzhyshkowska J, Gratchev A, Goerdt S. Stabilin-1, a homeostatic scavenger receptor with multiple functions. J Cell Mol Med 2006; 10(3): 635-49.
22. Politz O, Gratchev A, McCourt PA, et al. Stabilin-1 and-2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002; 362(Pt 1): 155-64.
23. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176(1): 287-92.
24. Gratchev A, Schledzewski K, Guillot P, Goerdt S. Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing. Skin Pharmacol Appl Skin Physiol 2001; 14(5): 272-9.
25. Lee YW, Kim PH, Lee WH, Hirani AA. Interleukin-4, Oxidative Stress, Vascular Inflammation and Atherosclerosis. Biomol Ther (Seoul) 2010; 18(2): 135-44.
26. Rollins BJ, Pober JS. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol 1991; 138(6): 1315-9.
27. Galea P, Lebranchu Y, Thibault G, Bardos P. Interleukin 4 and tumour necrosis factor alpha induce different adhesion pathways in endothelial cells for the binding of peripheral blood lymphocytes. Scand J Immunol 1992; 36(4): 575-85.
28. Huang H, Lavoie-Lamoureux A, Moran K, Lavoie JP. IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2007; 292(5): L1147-54.
29. Chen CC, Manning AM. TGF-beta 1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 1996; 8(1): 58-65.
30. Lee YW, Kuhn H, Hennig B, Toborek M. IL-4 induces apoptosis of endothelial cells through the caspase-3-dependent pathway. FEBS Lett 2000; 485(2-3): 122-6.
31. Davenport P, Tipping PG. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein Edeficient mice. Am J Pathol 2003; 163(3): 1117-25.
32. King VL, Szilvassy SJ, Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/-mice. Arterioscler Thromb Vasc Biol 2002; 22(3): 456-61.
33. Zhou X, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 1998; 101(8): 1717-25.
34. Teupser D, Burkhardt R, Wilfert W, Haffner I, Nebendahl K, Thiery J. Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance. Arterioscler Thromb Vasc Biol 2006; 26(2): 365-71.
35. Thomas AC, Sala-Newby GB, Ismail Y, Johnson JL, Pasterkamp G, Newby AC. Genomics of foam cells and nonfoamy macrophages from rabbits identifies arginase-I as a differential regulator of nitric oxide production. Arterioscler Thromb Vasc Biol 2007; 27(3): 571-7.
36. Kodelja V, Muller C, Politz O, Hakij N, Orfanos CE, Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 1998; 160(3): 1411-8.
37. Hagg DA, Olson FJ, Kjelldahl J, et al. Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques. Atherosclerosis 2009; 204(2): e15-e20.
38. Gratchev A, Guillot P, Hakiy N, et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001; 53(4): 386-92.
39. Gratchev A, Kzhyshkowska J, Kothe K, et al. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 2006; 211(6-8): 473-86.
40. Kzhyshkowska J, Mamidi S, Gratchev A, et al. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 2006; 107(8): 3221-8.
41. Gratchev A, Kzhyshkowska J, Duperrier K, Utikal J, Velten FW, Goerdt S. The receptor for interleukin-17E is induced by Th2 cytokines in antigen-presenting cells. Scand J Immunol 2004; 60(3): 233-7.
42. Gratchev A, Kzhyshkowska J, Kannookadan S, et al. Activation of a TGF-{beta}-Specific Multistep Gene Expression Program in Mature Macrophages Requires Glucocorticoid-Mediated Surface Expression of TGF-{beta} Receptor II. J Immunol 2008; 180(10): 6553-65.
43. Zhang J, Gratchev A, Riabov V, et al. A novel GGA-binding site is required for intracellular sorting mediated by stabilin-1. Mol Cell Biol 2009; 29(22): 6097-105.
44. Saenz SA, Siracusa MC, Perrigoue JG, et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010; 464(7293): 1362-6.
45. Popova A, Kzhyshkowska J, Nurgazieva D, Goerdt S, Gratchev A. Smurf2 regulates IL17RB by proteasomal degradation of its novel binding partner DAZAP2. Immunobiology 2012; 217(3): 321-8.
46. Pluddemann A, Neyen C, Gordon S. Macrophage scavenger receptors and host-derived ligands. Methods 2007; 43(3): 207-17.
47. Krusell L. Novel synaptotagmin-like protein KIAA1228: generation of tools and model systems for functional analysis. 2005.
48. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 2005; 182(1): 1-15.
49. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002; 111(7): 927-30.
50. Kzhyshkowska J, Gratchev A, Krusell L, et al. Stabilin-1-Multifunctional receptor linking endocytosis and secretion in macrophages. Cytokine 2009; 48(1-2): 34-35.
51. Kzhyshkowska J, Gratchev A, Martens JH, et al. Stabilin-1 localizes to endosomes and the trans-Golgi network in human macrophages and interacts with GGA adaptors. J Leukoc Biol 2004; 76(6): 1151-61.
52. Kzhyshkowska J, Gratchev A, Goerdt S. Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer. Biomarker Insights 2007; 2: 128-46.
53. Kzhyshkowska J, Gratchev A, Schmuttermaier C, et al. Alternatively Activated Macrophages Regulate Extracellular Levels of the Hormone Placental Lactogen via Receptor-Mediated Uptake and Transcytosis. J Immunol 2008; 180(5): 3028-3037.
54. Kzhyshkowska J, Gratchev A, Brundiers H, Mamidi S, Krusell L, Goerdt S. Phosphatidylinositide 3-kinase activity is required for stabilin-1-mediated endosomal transport of acLDL. Immunobiology 2005; 210(2-4): 161-73.
55. Brocheriou I, Maouche S, Durand H, et al. Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis. Atherosclerosis 2011; 214(2): 316-24.
56. Kzhyshkowska J, Neyen C, Gordon S. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 2012; 217(5): 492-502.
57. Tian E, Sawyer JR, Largaespada DA, Jenkins NA, Copeland NG, Shaughnessy JD, Jr. Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene 2000; 19(17): 2098-109.
58. Lee J, Ho WH, Maruoka M, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001; 276(2): 1660-4.
59. Wong CK, Cheung PF, Ip WK, Lam CW. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol 2005; 33(2): 186-94.
60. Wong CK, Li PW, Lam CW. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes. Immunol Lett 2007; 112(2): 82-91.
61. Maezawa Y, Nakajima H, Suzuki K, et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol 2006; 176(2): 1013-8.
62. Rickel EA, Siegel LA, Yoon BR, et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol 2008; 181(6): 4299-310.
63. Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007; 8(3): 247-56.
64. Swaidani S, Bulek K, Kang Z, et al. The critical role of epithelialderived Act1 in IL-17-and IL-25-mediated pulmonary inflammation. J Immunol 2009; 182(3): 1631-40.
65. Winkel A, Stricker S, Tylzanowski P, et al. Wnt-ligand-dependent interaction of TAK1 (TGF-beta-activated kinase-1) with the receptor tyrosine kinase Ror2 modulates canonical Wnt-signalling. Cell Signal 2008; 20(11): 2134-44.
66. Hayes S, Chawla A, Corvera S. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol 2002; 158(7): 1239-49.
67. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 1998; 95(6): 779-791.
68. Lukas J, Mazna P, Valenta T, et al. Dazap2 modulates transcription driven by the Wnt effector TCF-4. Nucleic Acids Res 2009; 37(9): 3007-20.
69. Cohen-Barak O, Yi Z, Hagiwara N, Monzen K, Komuro I, Brilliant MH. Sox6 regulation of cardiac myocyte development. Nucleic Acids Res 2003; 31(20): 5941-8.
70. Kim JE, Ryu I, Kim WJ, et al. Proline-rich transcript in brain protein induces stress granule formation. Mol Cell Biol 2008; 28(2): 803-13.
71. Roche DD, Liu KJ, Harland RM, Monsoro-Burq AH. Dazap2 is required for FGF-mediated posterior neural patterning, independent of Wnt and Cdx function. Dev Biol 2009; 333(1): 26-36.
72. Sommerfeldt DW, Zhi J, Rubin CT, Hadjiargyrou M. Proline-rich transcript of the brain (prtb) is a serum-responsive gene in osteoblasts and upregulated during adhesion. J Cell Biochem 2002; 84(2): 301-8.
73. Jonsson H, Peng SL. Forkhead transcription factors in immunology. Cell Mol Life Sci 2005; 62(4): 397-409.
74. Katoh M, Katoh M. Human FOX gene family (Review). Int J Oncol 2004; 25(5): 1495-500.
75. Shi C, Zhang X, Chen Z, et al. Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J Clin Invest 2004; 114(3): 408-18.
76. Webb NR, Moore KJ. Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy. Curr Drug Targets 2007; 8(12): 1249-63.
77. Shi C, Sakuma M, Mooroka T, et al. Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood 2008; 112(12): 4699-711.
78. Su D, Coudriet GM, Hyun KD, et al. FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages. Diabetes 2009; 58(11): 2624-33.
79. Senokuchi T, Liang CP, Seimon TA, et al. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes 2008; 57(11): 2967-76.
80. Song J, Ren P, Zhang L, Wang XL, Chen L, Shen YH. Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4. Biochem Biophys Res Commun 2010; 393(1): 89-94.
81. Bieller A, Pasche B, Frank S, et al. Isolation and characterization of the human forkhead gene FOXQ1. DNA Cell Biol 2001; 20(9): 555-61.
82. Kaneda H, Arao T, Tanaka K, et al. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer Res 2010; 70(5): 2053-63.
83. Feuerborn A, Srivastava PK, Kuffer S, et al. The Forkhead factor FoxQ1 influences epithelial differentiation. J Cell Physiol 2011; 226(3): 710-9.
84. Zhang H, Meng F, Liu G, et al. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res 2011; 71(4): 1292-301.